Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating MM-310 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations
- Status
- COMPLETED
- Phase
- PHASE2
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of BMS-986012 in Subjects With Small Cell Lung Caner
- Status
- COMPLETED
- Phase
- PHASE1
Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE2